inflammatory reaction? Third, according to the authors, the introduction of fibrinolytic therapy could not be completed in six patients because of hemorrhagic drainage after third or fourth doses. 1) What kind of treatment was necessary for these patients? Fourth, one patient developed pleural thickening in the follow-up period with partial response to treatment and required decortication via thoracotomy. 1) We would like to know when did this complication occur after treatment.
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